Revolution Medicines, Inc. (RVMD)
196.55
+14.40
(+7.91%)
USD |
NASDAQ |
Oct 20, 16:00
197.46
+0.91
(+0.46%)
After-Hours: 07:17
Revolution Medicines Gross Profit (TTM) : -18.08M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.08M |
| March 31, 2026 | -17.38M |
| December 31, 2025 | -16.56M |
| September 30, 2025 | -15.24M |
| June 30, 2025 | -13.77M |
| March 31, 2025 | -12.77M |
| December 31, 2024 | -11.81M |
| September 30, 2024 | -10.54M |
| June 30, 2024 | -9.821M |
| March 31, 2024 | -4.973M |
| December 31, 2023 | 2.271M |
| September 30, 2023 | 17.12M |
| June 30, 2023 | 20.19M |
| March 31, 2023 | 24.92M |
| December 31, 2022 | 25.72M |
| September 30, 2022 | 20.39M |
| Date | Value |
|---|---|
| June 30, 2022 | 19.47M |
| March 31, 2022 | 12.69M |
| December 31, 2021 | 7.398M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 9.656M |
| June 30, 2019 | 9.656M |
| March 31, 2019 | 9.656M |
| December 31, 2018 | 9.656M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Moderna, Inc. | 280.00M |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Intellia Therapeutics, Inc. | 44.25M |
| Oncolytics Biotech, Inc. | -0.11M |
| Twist Bioscience Corp. | 224.38M |